A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2006
12/26/2006	US7153515 Method of preventing T cell-mediated responses by the use of the major histocompatibility complex class II analog protein (map protein) from Staphylococcus aureus
12/26/2006	US7153514 Use of botulinum toxin therapy for prostatic hyperplasia and related disorders
12/26/2006	US7153513 West nile vaccine
12/26/2006	US7153512 Bovine immunodeficiency virus (BIV) based vectors
12/26/2006	US7153511 Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine
12/26/2006	US7153510 Recombinant vesiculoviruses and their uses
12/26/2006	US7153509 Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope
12/26/2006	US7153508 Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4
12/26/2006	US7153507 A human monoclonal antibody specifically binds to human IL-15 and to inhibit IL-15-induced proinflammatory effects; tumor necrosis factor; antiinflammatory, -arthritic, -carcinogenic, proliferative agents; rheumatic diseases; transplants
12/26/2006	US7153506 Treating cancer whereof the cells exhibit overexpression of a product of a gene of the myc-related family
12/26/2006	US7153499 Promoting differentiation and maturation of immature dendritic cells in a regional lymph node (especially by administering a natural cytokine mixture parilymphatically) so that the cells deliver T-cell antigen to effect immunization
12/21/2006	WO2006135862A2 Immunomodulation by altering sphingosine 1-phosphate lyase (spl) activity
12/21/2006	WO2006135602A2 Herpes virus-based compositions and methods of use in the prenatal and perinatal periods
12/21/2006	WO2006135454A1 Novel cancer cell lines and uses thereof
12/21/2006	WO2006135447A2 Viral chimera compositions and methods
12/21/2006	WO2006135428A2 Methods and compositions for inducing an immune response against multiple antigens
12/21/2006	WO2006135385A2 Antagonizing interleukin-21 receptor activity
12/21/2006	WO2006135263A1 Fibroblast growth factor receptor-5 antibodies and methods for their use
12/21/2006	WO2006134443A1 Dengue serotype 2 attenuated strain
12/21/2006	WO2006134390A2 Method for diagnosing neurodegenerative disease
12/21/2006	WO2006134368A1 Idiotype vaccination with bispecific and multispecific immunoglobulin molecules
12/21/2006	WO2006134125A1 Antigen conjugates and uses thereof
12/21/2006	WO2006133947A1 Highly attenuated pox virus strains, method for the production thereof and the use thereof as paramunity inducers or for producing vector vaccines
12/21/2006	WO2006133911A2 Hepatitis c virus nucleic acid vaccine
12/21/2006	WO2006133879A2 Vaccines for immunization against helicobacter
12/21/2006	WO2006133566A1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF
12/21/2006	WO2006133508A1 Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene
12/21/2006	WO2006133497A1 Combination treatment
12/21/2006	WO2006119264A3 Antibodies against histone modifications for clinical diagnosis and prognosis of cancer
12/21/2006	WO2006116001A3 Antibodies for the treatment of cancers
12/21/2006	WO2006113599A3 Methods of diagnosing inflammatory diseases of intestine
12/21/2006	WO2006113347A3 Diagnostic and therapeutic potential of immune globulin intravenous (igiv) products
12/21/2006	WO2006110367A3 Methods and compositions for mycoplasma toxins
12/21/2006	WO2006109045A3 Cathepsin s antibody
12/21/2006	WO2006109044A3 Selective modulation of tumour necrosis factor receptors in therapy
12/21/2006	WO2006100430A3 Polypeptides
12/21/2006	WO2006096461A3 Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent
12/21/2006	WO2006095180A3 Humananized monoclonal antibodies against sars - associated coronavirus and treatment of patients with sars
12/21/2006	WO2006091773A3 Compositions and methods related to serpin spi6
12/21/2006	WO2006089133A3 Anti-cd19 antibodies and uses in oncology
12/21/2006	WO2006088803A3 Polypeptides from staphylococcus aureus and methods of use
12/21/2006	WO2006084145A3 Methods of using il-1 antagonists to reduce c-reactive protein
12/21/2006	WO2006083852A3 Luca2 and antibodies that bind thereto
12/21/2006	WO2006083289A3 Methods and compositions for enhancement of immunity by in vivo depletion of immunosuppressive cell activity
12/21/2006	WO2006080946A3 Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist
12/21/2006	WO2006078271A3 Cloning and expression of the full length 110 kda antigen of orientia tsutsugamushi to be used as a vaccine component against scrub typhus
12/21/2006	WO2006073827A3 Neutralizing epitope-based growth enhancing vaccine
12/21/2006	WO2006070371A3 Method for obtaining modified proteins and viruses with intact native binding site
12/21/2006	WO2006053871A3 Multivalent vaccines comprising recombinant viral vectors
12/21/2006	WO2006050420A3 Chimeric immunogens that comprise ovalbumin
12/21/2006	WO2006036371A3 Combination therapy
12/21/2006	WO2006026508A3 Modified hiv-1 envelope proteins
12/21/2006	WO2006014999A3 Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease
12/21/2006	WO2005124351A8 A sensitive antibody-based method for detecting cryptosporidium parvum oocysts in water
12/21/2006	WO2005100399A3 Dr5 antibodies and uses thereof
12/21/2006	WO2005062967A3 Novel anti-il 13 antibodies and uses thereof
12/21/2006	WO2005018535A3 Compositions and methods for treatment of severe acute respiratory syndrome (sars)
12/21/2006	WO2004069184A3 Methods for treating, preventing and detecting helicobacter infection
12/21/2006	WO2004066828A3 Apparatus for endoscopic surgical procedures
12/21/2006	WO2004063332A3 Cancer related genes
12/21/2006	WO2003054144A3 Human ras interacting protein
12/21/2006	US20060288434 Inhibiting angiogenesis in a mammal by administering an antibody which specifically binds to EphriniB2 or EphB4; cardiovascular disorders
12/21/2006	US20060287513 Compositions and methods for the therapy and diagnosis of breast cancer
12/21/2006	US20060287508 Methods for stabilizing proteins
12/21/2006	US20060287504 Universal procedure for refolding recombinant proteins
12/21/2006	US20060287502 C3b/C4b complement receptor-like molecules and uses thereof
12/21/2006	US20060287281 Phosphohalohydrins, process for the production thereof and use thereof
12/21/2006	US20060287262 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
12/21/2006	US20060287258 administering to the female an antibody that reduces the effect of prokineticin 1 on a prokineticin receptor to treat endometriosis; gonadotropin releasing hormone (GnRH) antagonist is selected from teverelix, abarelix, cetroelix or ganirelix antagonises the estrogen receptor
12/21/2006	US20060287230 Compositions which can be used for regulating the activity of parkin
12/21/2006	US20060287223 Remodeling and glycoconjugation of peptides
12/21/2006	US20060286670 Transplant acceptance inducing cells of monocytic origin and their preparation and use
12/21/2006	US20060286642 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
12/21/2006	US20060286634 Vector
12/21/2006	US20060286556 Autoimmune encephalomyelitis; multiple sclerosis; antagonize or inhibit CXCL13
12/21/2006	US20060286128 Adjuvant combinations of liposomes and mycobacteriaial lipids for immunization compositions and vaccines
12/21/2006	US20060286127 Treatment of autoimmune disorder with a neurotoxin
12/21/2006	US20060286126 preparing closed bacterial ghosts by specific interactions between partners of a bioaffinity binding pair; operate with a higher degree of efficiency
12/21/2006	US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis
12/21/2006	US20060286124 Vaccine compositions and methods of treating coronavirus infection
12/21/2006	US20060286123 Porcine Respiratory Reproductive Syndrome (PRRS); viral disease affecting pigs
12/21/2006	US20060286122 Modulation of angiogenesis by Bartonella henselae
12/21/2006	US20060286121 Adenoviral vector-based vaccines
12/21/2006	US20060286119 Compositions and methods for treatment of chronic and infectious diseases
12/21/2006	US20060286118 Lawsonia intracllularis subunit vaccine
12/21/2006	US20060286117 Neuronally expressed stem cell factor modulates angiogenesis and neural stem cell migration to areas of brain injury
12/21/2006	US20060286116 Methods and compositions for treating B cell cancer
12/21/2006	US20060286115 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule
12/21/2006	US20060286114 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
12/21/2006	US20060286113 single domain antibody AFAI; binds to non-small cell lung carcinoma; kits
12/21/2006	US20060286112 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
12/21/2006	US20060286111 Tumor necrosis factor related ligand
12/21/2006	US20060286110 Bax-responsive genes for drug target identification in yeast and fungi
12/21/2006	US20060286109 Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen
12/21/2006	US20060286108 Topical compositions for the treatment of chronic wounds
12/21/2006	US20060286107 Parathyroid hormone antibodies and related methods
12/21/2006	US20060286106 determining total protein bound or total free levels or both of one or more myeloperoxidase (MPO)-generated amino acids in a bodily sample of blood, serum, plasma, or urine from the patient
12/21/2006	US20060286105 Tgf-beta antagonists combined with renin-angiotensin-aldosteron-system antagonists for treating renal insufficiency
12/21/2006	US20060286104 Superagonistic anti-CD28 antibodies
12/21/2006	US20060286103 Stable antibody formulation

1 ... 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 ... 1823